1. Assessing the Anti-inflammatory Mechanism of Reduning Injection by Network Pharmacology. (16th December 2020) Authors: Xie, Fuda; Xie, Mingxiang; Yang, Yibing; Zhang, Miaomiao; Xu, Xiaojie; Liu, Na; Xiao, Wei; Gu, Jiangyong Other Names: Wang Bing Academic Editor. Journal: BioMed research international Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cyclin‐dependent kinase 12‐mediated super‐enhancers as promising targets in cancer therapy. Issue 4 (6th November 2022) Authors: Xie, Fuda; Chen, Bonan; Liu, Xiaoli; Yu, Jun; To, Ka Fai; Kang, Wei Journal: Clinical and translational discovery Issue: Volume 2:Issue 4(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Fangchinoline inhibits non-small cell lung cancer metastasis by reversing epithelial-mesenchymal transition and suppressing the cytosolic ROS-related Akt-mTOR signaling pathway. (1st September 2022) Authors: Chen, Bonan; Song, Yue; Zhan, Yujuan; Zhou, Shikun; Ke, Junzi; Ao, Weizhen; Zhang, Yigan; Liang, Qiqi; He, Minhui; Li, Shuhui; Xie, Fuda; Huang, Haonan; Chan, Wai Nok; Cheung, Alvin H.K.; Ma, Brigette B.Y.; Kang, Wei; To, Ka Fai; Xiao, Jianyong Journal: Cancer letters Issue: Volume 543(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Mint3‐targeted therapy: A novel therapeutic strategy for urothelial carcinoma. Issue 1 (31st January 2023) Authors: Xie, Fuda; Chen, Bonan; Cheung, Alvin H.K.; Yu, Jun; To, Ka Fai; Kang, Wei Journal: Clinical and translational discovery Issue: Volume 3:Issue 1(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Multi-target mechanisms against coronaviruses of constituents from Chinese Dagang Tea revealed by experimental and docking studies. (28th October 2022) Authors: Zhao, Liyun; Qin, Xubing; Lin, Tingting; Xie, Fuda; Yao, Liyuan; Li, Yulin; Xiong, Binhong; Xu, Zhifang; Ye, Yongchang; Chen, Hongfeng; Qiu, Sheng-Xiang Journal: Journal of ethnopharmacology Issue: Volume 297(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pathway network-based quantitative modeling of the time-dependent and dose-response anti-inflammatory effect of Reduning Injection. (10th May 2023) Authors: Xie, Fuda; Xie, Mingxiang; Yang, Yibing; Ao, Weizhen; Zhao, Tingxiu; Liu, Na; Chen, Bonan; Kang, Wei; Xiao, Wei; Gu, Jiangyong Journal: Journal of ethnopharmacology Issue: Volume 307(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Rosmarinic acid protects mice from imiquimod induced psoriasis‐like skin lesions by inhibiting the IL‐23/Th17 axis via regulating Jak2/Stat3 signaling pathway. (18th May 2021) Authors: Zhang, Miaomiao; Li, Ning; Cai, Ruhang; Gu, Jiangyong; Xie, Fuda; Wei, Hong; Lu, Chuanjian; Wu, Dinghong Journal: Phytotherapy research Issue: Volume 35:Number 8(2021) Page Start: 4526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The crosstalk between the RNA demethylase, non‐coding RNAs, and transcription factors in gastric cancer: An ALKBH5 perspective. Issue 2 (11th April 2023) Authors: Xie, Fuda; Chen, Bonan; Cheung, Alvin H. K.; Yu, Jun; To, Ka Fai; Kang, Wei Journal: Clinical and translational discovery Issue: Volume 3:Issue 2(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗